ISSN 0042-0018
Vol. 41, Issue 2, 2006January 01, 2006 PDT
FDA, CLIA, or a “Reasonable Combination of Both”: Toward Increased Regulatory Oversight of Genetic Testing
FDA, CLIA, or a “Reasonable Combination of Both”: Toward Increased Regulatory Oversight of Genetic Testing
Douglas A. Grimm, FDA, CLIA, or a “Reasonable Combination of Both”: Toward Increased Regulatory Oversight of Genetic Testing, 41 U.S.F. L. Rev. 1 (2006).